Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Smoking Cessation Interventions in Pulmonary Tuberculosis Patients
NCT04848246Completed
- Sponsor
- Dow University of Health Sciences
- Start
- Nov 2017
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of bupropion in Tobacco Use Disorder (TUD) (3 arms), sponsored by Dow University of Health Sciences. Primary endpoint: Percentage of patients completing anti-tuberculosis treatment at 6 months. Started Nov 2017; status: completed.
02
Drugs
bupropion
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT04848246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04848246.